Keyphrases
ACR Appropriateness Criteria
100%
Advanced Imaging
20%
Aggressiveness
20%
Assessment Development
20%
Bone Metastasis
20%
Bone Scintigraphy
20%
Clinical Conditions
20%
Clinical Scenarios
20%
Detection Localization
20%
Detection Rate
20%
Digital Rectal Examination
20%
Disease Diagnosis
20%
Evaluation Assessment
20%
Evidence-based Guidelines
20%
Expert Opinion
20%
Expert Panel
20%
Extent of Disease
20%
Grading of Recommendations
20%
Guideline Development
20%
Guideline Revision
20%
High-grade Prostate Cancer
20%
Imaging Procedures
20%
Improved Detection
20%
Intermediate-risk Prostate Cancer
20%
Intravenous Contrast
20%
Leading Causes of Death
20%
Lung Cancer
20%
Malignancy
20%
Medical Literature
20%
Membrane Antigens
20%
MRI-guided Biopsy
20%
Multiparametric MRI (mpMRI)
20%
Nodal Metastasis
20%
Patient Characteristics
20%
Patient Outcomes
20%
Peer-reviewed Journals
20%
Positron Emission Tomography-computed Tomography (PET-CT)
20%
Prostate Cancer
100%
Prostate-specific Antigen Level
20%
RAND Appropriateness Method
20%
Recommendation Method
20%
Standard of Care
20%
Tissue Diagnosis
20%
Total Prostate-specific Antigen
20%
Transrectal Biopsy
20%
Treatment Methods
20%
Treatment Verification
20%
Whole-body MRI
20%
Medicine and Dentistry
Biopsy Technique
33%
Bone Scintigraphy
16%
Cancer
16%
Digital Rectal Examination
16%
Diseases
33%
Lung Cancer
16%
Magnetic Resonance Imaging
33%
Membrane Antigen
16%
Nodal Metastasis
16%
Positron Emission Tomography-Computed Tomography
16%
Prostate Cancer
100%
Prostate Specific Antigen
16%
Recurrent Disease
16%
Transrectal Ultrasonography
16%
Whole Body MRI
16%